Free Trial

Nutrien (NTR) Stock Forecast & Price Target

Nutrien logo
$60.64 +0.89 (+1.48%)
As of 10:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
6
Buy
9

Based on 17 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 6 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for NTR.

Consensus Price Target

$61.44
1.32% Upside
According to the 17 analysts' twelve-month price targets for Nutrien, the average price target is $61.44. The highest price target for NTR is $75.00, while the lowest price target for NTR is $50.00. The average price target represents a forecasted upside of 1.32% from the current price of $60.64.
Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

Sign Up

NTR Analyst Ratings Over Time

TypeCurrent Forecast
6/4/24 to 6/4/25
1 Month Ago
5/5/24 to 5/5/25
3 Months Ago
3/6/24 to 3/6/25
1 Year Ago
6/5/23 to 6/4/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
9 Buy rating(s)
12 Buy rating(s)
Hold
6 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$61.44$59.27$59.94$67.32
Forecasted Upside1.32% Upside5.46% Upside17.33% Upside17.68% Upside
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Hold

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutrien Stock vs. The Competition

TypeNutrienBasic Materials CompaniesS&P 500
Consensus Rating Score
2.47
2.77
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside2.75% Upside132.95% Upside14.15% Upside
News Sentiment Rating
Positive News

See Recent NTR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/22/2025Scotiabank
5 of 5 stars
B. Isaacson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$62.00+5.03%
5/14/2025Barclays
3 of 5 stars
B. Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$59.00 ➝ $61.00+7.99%
5/14/2025Bank of America
4 of 5 stars
Steve Byrne
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$60.00 ➝ $63.00+10.53%
5/13/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kristen Owen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$58.00 ➝ $63.00+8.73%
5/12/2025TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$64.00 ➝ $67.00+19.76%
5/12/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Richard Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$56.00 ➝ $59.00+5.43%
5/12/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrew Wong
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$60.00 ➝ $65.00+16.70%
5/9/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Fischer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSell ➝ Sell$53.00 ➝ $59.00+6.75%
5/8/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Eric Beaumont
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$52.00 ➝ $56.00+2.90%
4/15/2025Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$54.00 ➝ $59.00+12.75%
4/9/2025BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Symonds
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/25/2025CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperformer ➝ Outperformer$64.00 ➝ $66.00+24.22%
2/20/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christopher Parkinson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$52.00 ➝ $55.00+3.55%
1/27/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Neivert
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$58.00 ➝ $63.00+18.27%
1/13/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeffrey Zekauskas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$40.00 ➝ $50.00+3.18%
12/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Hansen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$58.00 ➝ $60.00+25.63%
8/9/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$80.00 ➝ $75.00+63.58%
8/2/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/2/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Reduce
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$62.00+17.92%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$66.00+26.36%
1/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+49.31%
7/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$70.00+5.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:38 AM ET.


Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 3, 2025. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • The current stock price is around $59, reflecting a stable market position and potential for growth.
  • Recent analyst upgrades have increased target prices, indicating positive market sentiment and potential for stock appreciation.
  • Nutrien Ltd. has a strong institutional ownership, with over 63% of shares held by institutional investors, suggesting confidence in the company's future.
  • The company recently declared a quarterly dividend of $0.545 per share, providing a steady income stream for investors.
  • Nutrien Ltd. operates in multiple segments, including Retail, Potash, Nitrogen, and Phosphate, diversifying its revenue sources and reducing risk.

Nutrien
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • The company reported a decline in revenue year-over-year, which may indicate challenges in maintaining growth.
  • Nutrien Ltd. has a high payout ratio of 203.74%, suggesting that it may be returning more to shareholders than it is earning, which could be unsustainable.
  • Despite recent upgrades, some analysts still rate the stock as a "sell," indicating mixed opinions on its future performance.
  • The stock has experienced fluctuations, with a 12-month high of $60.50 and a low of $43.70, reflecting volatility that could concern risk-averse investors.
  • The company's earnings per share (EPS) missed consensus estimates recently, which could signal underlying operational issues.

NTR Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $61.44, with a high forecast of $75.00 and a low forecast of $50.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 2 sell ratings, 6 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.

According to analysts, Nutrien's stock has a predicted upside of 1.32% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.


This page (NYSE:NTR) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners